Ensol Biosciences Inc. (XKON:140610)
South Korea · Delayed Price · Currency is KRW 8,600.00
-190.00 (-2.16%)
At close: Nov 5, 2026
Ensol Biosciences Revenue
In the year 2017, Ensol Biosciences had annual revenue of 537.46M KRW with 208.94% growth. That makes Ensol Biosciences the 44,799th largest company in the world by revenue and 2,600th in South Korea.
Revenue
537.46M
Revenue Growth
+208.94%
P/S Ratio
230.04
Revenue / Employee
n/a
Employees
n/a
Market Cap
123.64B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2017 | 537.46M | 363.49M | 208.94% |
| Dec 31, 2016 | 173.97M | -28.02M | -13.87% |
| Dec 31, 2015 | 201.99M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.